Crushing lopinavir-ritonavir tablets may decrease the efficacy of therapy in COVID-19 patients

Journal article

Open access

Peer reviewed

Khalid Eljaaly and Jaffar A Al-Tawfiq

Travel medicine and infectious disease, Vol.38, pp.101749-101749

01/11/2020

PMID: 32473994

Abstract

Adult

COVID-19

Humans

Lopinavir - therapeutic use

Ritonavir - therapeutic use

SARS-CoV-2

Tablets

url

https://doi.org/10.1016/j.tmaid.2020.101749View

Published (Version of record) Open

1 Record Views

Title: Crushing lopinavir-ritonavir tablets may decrease the efficacy of therapy in COVID-19 patients
Creators - without role: Khalid Eljaaly - King Abdulaziz University
Jaffar A Al-Tawfiq - Indiana University
Publication Details: Travel medicine and infectious disease, Vol.38, pp.101749-101749
Identifiers: 9935454408331
Academic Unit: King Abdulaziz University
Language: English
Resource Type: Journal article